Brought to you by 
Danaher pays $352mm for urinalysis firm IRIS International
21 Sep 2012
Executive Summary
Medical and industrial products manufacturer Danaher Corp. is acquiring publicly traded IRIS International Inc. (body fluid analysis, sample processing, and early disease detection) for $352mm, or $19.50 per share (a 51% premium).
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Laboratory Testing Services
- Medical Devices
- Services
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Hematology, Coagulation
- Molecular Diagnostics & Genetic Testing
- Urine-based Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Danaher pays $352mm for urinalysis firm IRIS International
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice